Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer von BURCOMBE, R. J, MAKRIS, A, RICHMAN, P. I, DALEY, F. M, NOBLE, S, PITTAM, M, WRIGHT, D, ALLEN, S. A, DOVE, J, WILSON, G. D

Volltext

Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography von Burcombe, R.J, Makris, A, Pittam, M, Lowe, J, Emmott, J, Wong, W.L

Volltext

Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual von Burcombe, R.J, Makris, A, Pittam, M, Finer, N

Volltext

A systematic review of the role of pulmonary irradiation in the management of primary bone tumours von Whelan, J. S., Burcombe, R. J., Janinis, J., Baldelli, A. M., Cassoni, A. M.

Volltext

Hyperhomocysteinemia in women with advanced breast cancer von GATT, A., MAKRIS, A., CLADD, H., BURCOMBE, R. J., SMITH, J. M., COOPER, P., THOMPSON, D., MAKRIS, M.

Volltext

The Role of Staging CT Scans in the Treatment of Prostate Cancer: A Retrospective Audit von Burcombe, R.J., Ostler, P.J., Ayoub, A.W., Hoskin, P.J.

Volltext

Variations in dose and dose intensity of adjuvant CMF chemotherapy for breast cancer throughout the UK von BROWN, R. S. D, BURCOMBE, R. J, OSBORNE, M. E, GAZE, M. N

Volltext

Massive Mediastinal Seminoma Post-orchidectomy Late relapse with Skip-metastases or New Primary? von BROWN, R. S. D, HAYNE, D, BURCOMBE, R. J, HARBIN, L. J, COUITER, C. A. E

Volltext

Evaluation of tumour microvessel density & pericyte coverage index following neoadjuvant chemotherapy in primary breast cancer von Ah-See, M. L. W., Burcombe, R. J., Daley, F. M., Richman, P. I., Padhani, A. R., Bentzen, S. M., Fox, S. B., Harris, A. L., Makris, A.

Volltext

Does vascular imaging with MRI predict response to neoadjuvant chemotherapy in primary breast cancer? von Ah-See, M.-L. W., Makris, A., Taylor, N. J., Burcombe, R. J., Harrison, M., Stirling, J. J., Richman, P. I., Leach, M. O., Padhani, A. R.

Volltext

Does vascular imaging with MRI predict response to neoadjuvant chemotherapy in primary breast cancer? von Ah-See, M.-L. W., Makris, A., Taylor, N. J., Burcombe, R. J., Harrison, M., Stirling, J. J., Richman, P. I., Leach, M. O., Padhani, A. R.

Volltext

Variations in Dose and Dose Intensity of Adjuvant CMF Chemotherapy for Breast Cancer Throughout the UK von Brown, R.S.D., Burcombe, R.J., Osborne, M.E., Gaze, M.N.

Volltext

The Role of Staging CT Scans in the Treatment of Prostate Cancer: A Retrospective Audit von Burcombe, R. J., Ostler, P. J., Ayoub, A. W., Hoskin, P. J.

Volltext

Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer von AH-SEE, Mei-Lin W, MAKRIS, Andreas, RAVICHANDRAN, Duraisamy, PADHANI, Anwar R, TAYLOR, N. Jane, HARRISON, Mark, RICHMAN, Paul I, BURCOMBE, Russell J, STIRLING, J. James, D'ARCY, James A, COLLINS, David J, PITTAM, Michael R

Volltext

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial von Kunkler, Ian H, Prof, Williams, Linda J, PhD, Jack, Wilma J L, MBChB, Cameron, David A, Prof, Dixon, J Michael, Prof

Volltext

The impact of neoadjuvant dual HER2 targeting with pertuzumab and trastuzumab on pathological complete response (pCR) rates: Kent Oncology Centre (KOC) experience von Forner, S., Sim, V.R., Glendenning, J.L., Burcombe, R.

Volltext

223PThe impact of neoadjuvant dual HER2 targeting with pertuzumab and trastuzumab on pathological complete response (pCR) rates: Kent Oncology Centre (KOC) experience von Forner, S, Sim, V R, Glendenning, J L, Burcombe, R

Volltext

Eribulin Use and Palliative Care Referral Rates in Metastatic Breast Cancer: Kent Oncology Centre Experience von Little, J., Burcombe, R., Parsons, E., Ryan, C.

Volltext

PO-0882: Single centre review of the survival benefit and toxicity of PCI in Small Cell Lung Cancer von Forner, S., Vasiliadou, I., Little, J., Fenton, M., Goyal, S., Burcombe, R., Brulinski, P., Sevitt, T.

Volltext

Implementation of Oncotype Dx to Guide Chemotherapy Sparing for Women with Postmenopausal N1-3, ER-positive, HER-2-negative Breast Cancer von Rajakumar, L., Glendenning, J., Hall, J., Burcombe, R., McCormick, G., Hegarty, G., Harper-Wynne, C., Brown, B., Moss, C., Thomas, C., Jyothirmayi, R., Osman, M., Nikiforidis, L.

Volltext